Company Avisa Diagnostics Inc. Canadian Securities Exchange
Equities
MKU.H
CA05380J1075
Biotechnology & Medical Research
Business Summary
Sales per Business
CAD in Million | 2019 | Weight | 2020 | Weight | Delta |
---|---|---|---|---|---|
Consulting
95.8
%
| 1 | 93.8 % | 0 | 95.8 % | -65.79% |
Support and Maintenance
4.2
%
| 0 | 2.1 % | 0 | 4.2 % | -33.90% |
Sales per region
CAD in Million | 2019 | Weight | 2020 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -66.52% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 81 | 21-04-19 | |
Director of Finance/CFO | 58 | 21-06-21 | |
Barbara Bunger
CTO | Chief Tech/Sci/R&D Officer | - | 21-06-01 |
Richard Murray
CTO | Chief Tech/Sci/R&D Officer | - | 21-08-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 81 | 21-04-19 | |
Brian Birk
BRD | Director/Board Member | 64 | 21-04-19 |
Rajeev Dewan
BRD | Director/Board Member | 51 | 21-04-19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 58,935,784 | 58,935,784 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |